GlassScriptPhysician profile
Amy L Cooper
NPI 1306880398
$49,782.15
in general payments reported to CMS, 2019-2025
18 companies · $10K in 2025
The $10K reported for 2025 was more than what 91% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,648 · 2020: $311 · 2021: $315 · 2022: $20K · 2023: $13K · 2024: $2,420 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $21K · Food and Beverage: $2,811 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Travel and Lodging: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $20,766.91 |
| Food and Beverage | $2,811.46 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Travel and Lodging | $745.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $46,764.67 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $1,178.84 | 2019-2025 | Arista, Arista Ah Flexitip |
| Gen-Probe, INC. | $340.27 | 2019 | |
| Myriad Genetic Laboratories, INC. | $269.03 | 2023-2024 | Myrisk, Precisetumor |
| Seagen INC. | $246.09 | 2022-2023 | Tivdak |
| Tesaro, INC. | $229.05 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $209.42 | 2022-2024 | Lynparza, Farxiga |
| Glaxosmithkline, LLC. | $111.71 | 2021 | |
| Pfizer INC. | $100.80 | 2024 | |
| Clovis Oncology, INC. | $99.00 | 2020 | |
| Merck Sharp & Dohme LLC | $70.60 | 2025 | |
| Mindray Ds USA, INC. | $49.65 | 2023 | Te7 Max, Te X |
| Hologic Sales and Service, LLC | $40.62 | 2023 | Thinprep 2000 Processor, Aptima |
| Astellas Pharma US INC | $15.81 | 2024 | Veozah |
| Csl Behring | $15.34 | 2024 | Kcentra |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $14.58 | 2019 | |
| Abbvie INC. | $13.56 | 2019 | |
| Therapeuticsmd, INC. | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.